Clinical Trial Update: Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating bone marrow mononuclear cells with hyperbaric oxygen therapy for Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Bone Marrow Mononuclear Cells (bone marrow mononuclear cells)
• Hyperbaric Oxygen Therapy

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED